Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 1416 of 5804
-
AI vs. microscope: could computer diagnosis replace lab tests for colon polyps?
Diagnosis OngoingColonoscopic removal of adenomatous polyps reduce both the incidence and mortality of colorectal cancer (CRC). The common clinical management of colorectal polyp detected during colonoscopy is to remove them and send for histopathology to determine the subsequent surveillance int…
Phase: NA • Sponsor: Chinese University of Hong Kong • Aim: Diagnosis
Last updated Jun 27, 2026 12:23 UTC
-
New antibody drug conjugate enters first human trial for advanced cancers
Disease control OngoingThis first-in-human study will evaluate the safety, tolerability, pharmacokinetics, and antitumor activity of TORL-3-600 in patients with advanced cancer
Phase: PHASE1 • Sponsor: TORL Biotherapeutics, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
Can your genes help you quit smoking? new study tests personalized approach
Disease control Recruiting nowThis study examines the application of precision treatment intervention for smoking cessation from both the clinician perspective and patient perspective, and compares it to usual care on tobacco treatment in the primary care setting. The precision treatment intervention includes…
Phase: NA • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
Shorter radiation course could spare breast appearance in Low-Risk cancer
Disease control OngoingThis phase II trial tests how well accelerated partial breast irradiation (APBI) delivered once per day works in ensuring an acceptable breast appearance in patients with low risk, hormone responsive breast cancer. APBI uses precise radiation beams to kill cancerous cells in a sm…
Phase: PHASE2 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jul 01, 2026 00:00 UTC
-
New drug cocktail shows promise against tough cancers
Disease control CompletedThe purpose of this study is to evaluate pathologic complete response (pCR) rate of coformulated favezelimab/pembrolizumab (MK-4280A) or pembrolizumab as assessed by blinded central pathology review (BICR) in participants with cutaneous squamous cell carcinoma (cSCC) \[Cohort A\]…
Phase: PHASE2 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Yearly shots could shield CLL patients from deadly infections
Prevention Recruiting nowThis phase II trial compares the effect of initial vaccination (PCV20 followed by PSV23) with yearly vaccinations of PSV23 to the standard 5 year vaccination in patients with chronic lymphocytic leukemia. At present chronic lymphocytic leukemia patients are poorly protected by an…
Phase: PHASE2 • Sponsor: Seema Bhat • Aim: Prevention
Last updated Jun 27, 2026 08:08 UTC
-
Experimental combo therapy aims to outsmart lymphoma
Disease control Recruiting nowThis phase I trial studies the safety and feasibility of cytomegalovirus (CMV) specific CD19-chimeric antigen receptor (CAR) T cells in combination with the CMV-modified vaccinia Ankara (MVA) triplex vaccine following lymphodepletion in treating patients with intermediate or high…
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
MRI-Guided radiation tailors treatment for anal cancer patients
Disease control Recruiting nowThe proposed study is a phase II, single arm, open-label trial of MR-guided radiation therapy (RT) with risk stratified RT dose selection in patients with anal cancer. Based on previous data, a risk adaptive treatment approached is proposed in 4 groups: Low risk, standard risk, i…
Phase: PHASE2 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 13:08 UTC
-
New heart catheter zaps away irregular rhythms without heat or cold
Disease control CompletedThe purpose of this pragmatic study is to evaluate the safety, performance and effectiveness of the VARIPULSE catheter technology used in combination with the TRUPULSE™ Generator, and the compatible EAM system (Carto 3D) to treat patients with atrial fibrillation and related arrh…
Phase: NA • Sponsor: Vivek Reddy • Aim: Disease control
Last updated Jun 26, 2026 13:00 UTC
-
Could a Low-Dose seizure drug quiet Parkinson's psychosis?
Symptom relief Recruiting nowThis clinical trial will test whether AGB101 (low-dose levetiracetam, 220 mg, extended release tablet) can improve symptoms of psychosis in Parkinson's disease. Participants will be asked to complete up to 5 in-person study visits over approximately 20 weeks. Participants will re…
Phase: PHASE2 • Sponsor: Johns Hopkins University • Aim: Symptom relief
Last updated Jun 27, 2026 07:54 UTC
-
At-Home HPV test kit aims to boost cervical cancer screening in underserved women
Prevention OngoingRegularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women and persons with a cervix. This study is a supplement to increase representation of Asian and Asian American women in a pragmatic clinical trial that evalu…
Phase: NA • Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 27, 2026 07:54 UTC
-
Can churches help close the heart health gap? new study tests community approach
Disease control OngoingCardiovascular disease (CVD) is the leading cause of death in the US general population. Although CVD mortality rates declined for both Black and White populations during the past two decades, they are still higher in Black adults than White adults. There are also persistent disp…
Phase: NA • Sponsor: Tulane University • Aim: Disease control
Last updated Jun 27, 2026 13:00 UTC
-
New drug combo aims to stall advanced cancers
Disease control Recruiting nowThis phase I/II trial studies the side effects and best dose of temozolomide and M1774 and how well they works in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) and may have spread to nearby tissue…
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
Could CBD calm Alzheimer's agitation? new trial aims to find out
Symptom relief Recruiting nowCALM-IT is a Randomized, double-blind, placebo-controlled cross-over clinical trial. Safety and efficacy of cannabidiol (CBD) capsules assessed for managing agitation in patients with AD and to identify novel biomarkers of agitation severity and treatment response.
Phase: PHASE2 • Sponsor: Sunnybrook Health Sciences Centre • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug aims to stop strokes from coming back
Disease control Recruiting nowSTARS is a prospective, multicentre, open-label, dose escalation, Phase IIa study to assess the safety and tolerability of TBO-309, an adjuvant antiplatelet therapy, in patients with AIS. Acute ischaemic stroke (AIS) is caused by a severe blockage of an artery leading to immedia…
Phase: PHASE2 • Sponsor: The Florey Institute of Neuroscience and Mental Health • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New scan could spot parathyroid tumors that old tests miss
Diagnosis Recruiting nowThis study proposes the use of a well-established PET isotope, Fluorine-18 (18F), bound to Choline, for a prospective single-center, single-arm study for participants with suspected parathyroid adenoma and negative or equivocal standard of care 99mTc Sestamibi SPECT/CT
Phase: PHASE2, PHASE3 • Sponsor: Andrei Iagaru • Aim: Diagnosis
Last updated Jun 27, 2026 14:02 UTC
-
New asthma drug shows promise in taming tough coughs
Disease control CompletedThis study assesses the impact of tezepelumab treatment not only on asthma control but also on cough specific Health-Related Quality of Life (HRQoL). Asthma control can be evaluated using Asthma Control Questionnaire (ACQ). Cough symptom which is one of the symptoms related airwa…
Sponsor: AstraZeneca • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
Natural compound berberine takes on Schizophrenia's hidden symptoms
Symptom relief ENROLLING_BY_INVITATION"Negative" symptoms are a major challenge for people with schizophrenia (SZ) and are a key reason why they struggle with everyday functioning. While current medications work well for the "positive" symptoms (like hallucinations or delusions), they aren't very effective at improvi…
Phase: NA • Sponsor: Tianjin Anding Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 09:00 UTC
-
New drug combo targets rare cancers in tiny trial
Disease control OngoingThis phase II trial tests how well atezolizumab works in combination with tiragolumab in treating patients with rare solid tumors that may have spread from where they first started to nearby tissue, lymph nodes, or distant parts of the body (advanced stage). Immunotherapy with mo…
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New drug aims to regrow hair in severe alopecia
Disease control CompletedThe primary objective of the study is to evaluate the safety of IMG-007 in adults with Alopecia Areata.
Phase: PHASE1, PHASE2 • Sponsor: Inmagene LLC • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC